Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kyverna Therapeutics, Inc.(KYTX) | 4,523,924 | 4,523,924 | 0 | $16.92M | $8.73M | 64.02% | -$8.19M |
| Allogene Therapeutics, Inc. | 1,798,163 | 1,798,163 | 0 | $3.83M | $2.63M | 19.25% | -$1.20M |
| Kronos Bio, Inc. | 2,765,314 | 2,765,314 | 0 | $2.63M | $2.28M | 16.73% | -$345.7K |
| Centessa Pharmaceuticals plc | 3,931,818 | 0 | -3,931,818 | $65.86M | $0 | — | -$65.86M |
| Dyne Therapeutics, Inc.(DYN) | 407,499 | 0 | -407,499 | $9.60M | $0 | — | -$9.60M |
| Tectonic Therapeutic, Inc.(TECX) | 1,028,674 | 0 | -1,028,674 | $47.49M | $0 | — | -$47.49M |